Publications by authors named "C de Roquetaillade"

In patients with acute brain injury (ABI), optimizing cerebral perfusion parameters relies on multimodal monitoring. This include data from systemic monitoring-mean arterial pressure (MAP), arterial carbon dioxide tension (PaCO), arterial oxygen saturation (SaO), hemoglobin levels (Hb), and temperature-as well as neurological monitoring-intracranial pressure (ICP), cerebral perfusion pressure (CPP), and transcranial Doppler (TCD) velocities. We hypothesized that these parameters alone were not sufficient to assess the risk of cerebral ischemia.

View Article and Find Full Text PDF
Article Synopsis
  • Imported malaria is becoming a significant health issue in non-endemic countries, particularly due to increased global travel, prompting a study to explore cytokine profiles in affected individuals in France.
  • The research involved 278 adults with Plasmodium falciparum malaria, classifying them into uncomplicated (UM) and severe malaria (SM), with findings showing a notable association between high IL-10 levels and both disease severity and higher parasitemia.
  • The study revealed that many patients had undetectable cytokine levels at admission, indicating that routine cytokine testing may not be useful, but high IL-10 concentrations could be important for monitoring severe cases and potential infections.
View Article and Find Full Text PDF

Background: Effects of early mobilization are not well documented in patients with aneurysmal subarachnoid hemorrhage (aSAH). Only a few studies have investigated it through progressive mobilization protocols and suggested that it is safe and feasible. This study aimed to determine the impact of early out-of-bed mobilization (EOM) on 3-month functional outcome and cerebral vasospasm (CVS) occurrence in patients with aSAH.

View Article and Find Full Text PDF
Article Synopsis
  • Mid-regional pro-adrenomedullin (MR-proADM) levels are associated with mortality risk in COVID-19 patients, helping to differentiate between survivors and non-survivors.
  • A comprehensive review of studies showed that survivors had significantly lower MR-proADM levels compared to non-survivors, with specific statistical differences indicating strong significance.
  • The findings suggest that MR-proADM could be a valuable tool for assessing severity, guiding treatment decisions, and predicting patient outcomes; however, further large-scale studies are needed to confirm its diagnostic role.
View Article and Find Full Text PDF